Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Lipigem

Lipigem is a medicine containing the active ingredient(s) gemfibrozil. On this page you will find out more about Lipigem, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: gemfibrozil

Information for medicine and pack size:
Lipigem 600 mg film-coated tablet, 60

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

LIPIGEM is indicated as an adjunct to diet and other therapeutic measures for: *Severe hypertriglyceridaemia (Type IV and V) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. *Dyslipidaemia associated with diabetes. *Reduction of risk of coronary heart disease in patients with Type IIa and IIb hypercholesterolaemia. Because of potential toxicity such as malignancy, gallbladder disease, abdominal pain leading to appendectomy and other abdominal surgeries, an increased incidence in noncoronary mortality, and the 29% increase in all-cause mortality seen with the chemically and pharmacologically related drug, clofibrate, the potential benefits of gemfibrozil in treating Type IIa patients with elevations of LDL-cholesterol only are not likely to outweigh the risks. In a subgroup analysis of patients in the Helsinki Heart Study with above-median HDL-cholesterol values at baseline (greater than 1.2mmol/L), the incidence of serious coronary events was similar for gemfibrozil and placebo subgroups. NOTE: LIPIGEM IS INDICATED WHEN EXERCISE, WEIGHT LOSS AND SPECIFIC DIETARY OR OTHER NONDRUG MEASURES SUCH AS LIMITING ALCOHOL INTAKE HAVE FAILED. OTHER MEDICAL DISORDERS SUCH AS HYPOTHYROIDISM AND DIABETES SHOULD BE CONTROLLED AS MUCH AS POSSIBLE. PERIODIC DETERMINATION OF SERUM LIPIDS SHOULD BE OBTAINED DURING TREATMENT WITH LIPIGEM. THE DRUG SHOULD BE WITHDRAWN OR ADDITIONAL THERAPY INSTITUTED IF THE LIPID RESPONSE IS DEEMED INADEQUATE AFTER THREE MONTHS.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance 19MM X 9.2MM DEEP CONVEX, WHITE FILM COATED OBLONG TABLET, DEBOSSED "GL600" ON ONE SIDE AND "GREEK ALPHA SYMBOL" ON THE OTHER.

Images are the copyright of the Pharmacy Guild of Australia

Dosage Form Tablet, film coated
Route of administration Oral
Medicine schedule
60 tablets: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Bottle
Storage temperature Store below 25 degrees Celsius
Storage conditions No information available
Life time 18 Months
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback